Technology | March 07, 2011

EMR Software Receives Complete Ambulatory Certification

March 7, 2011 – A medical office electronic medical record (EMR) has received Complete EHR Ambulatory certification. Medstreaming’s EMR enables providers to demonstrate stage 1 meaningful use and qualify for funding under the American Recovery and Reinvestment Act (ARRA).

Tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, the software is stage 1-compliant for 2011/2012, in accordance with the criteria adopted by the Secretary of Health and Human Services.

“We are very proud that healthcare providers can now leverage our cloud-based Medical Office Suite to demonstrate stage 1 meaningful use and address the problems associated with medical data fragmentation between PACS and EMR systems,” said Wael Elseaidy, Medstreaming CEO.

The FDA-cleared software is one of the first and only integrated picture archiving and communications system (PACS) and EMR systems that provides a single back-end cloud database architecture.

“We are very impressed with the comprehensive nature of Medstreaming’s EMR package and how it integrates seamlessly into our network,” said Shawn Foley, CEO of Nevada Heart and Vascular. “By working directly on a single integrated EMR and PACS database, the technology allows much wider integration of all patient data, which supports a more robust continuum of patient care. The support from Medstreaming has been excellent as well and we look forward to our ongoing partnership.”

Medical Office for EMR is a comprehensive suite of offerings focused on enabling proactive patient care and increasing the efficiency of healthcare delivery. These include complete scheduling, provider dashboard and patient evaluation programs. Prescription and lab orders can be electronically sent while enabling an up-to-date database for each individual patient record. Patient reminders can be created based on diagnosis, medication, allergies, lab results and demographics. Quality assurance measures are found throughout the system, including the tracking of physician’s meaningful use measures and report generation.

Medical Office EMR is HIPAA-compliant, audits all user activity and tracks each user operation of patient information whether accessing, creating, updating or deleting. The system is highly interoperable and facilitates rapid communications either intra-clinical or inter-clinical with the referring physician.

For more information, visit www.medstreaming.com

Related Content

AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.
News | Artificial Intelligence | January 18, 2021
January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca
MRI of Nonferromagnetic Ballistics Suspended in Gelatin. 

MRI of Nonferromagnetic Ballistics Suspended in Gelatin. Scout (A), T1-weighted spin-echo (SE) (B), T2-weighted SE (C), T2-weighted gradient-recalled echo (GRE) (TR/TE, 500/10; D), and T2-weighted GRE (TR/TE, 700/30; E) MR images show jacket hollow point .45 automatic Colt pistol bullet (Corbon) (1), solid lead .45 Long Colt bullet (Winchester) (2), full metal jacket (FMJ) automatic Colt pistol bullet (Winchester) (3), 5.56-mm FMJ bullet (Federal Ammunition) (4), #7 lead shotgun pellet (Winchester) (5), and 5-mm lead air gun pellet (Sheridan) (6). On all sequences, metallic artifact is minimal. Although metallic artifact increases or blooms with increased TR/TE in GRE images (D and E), amount of surrounding distortion is still minimal.

News | Magnetic Resonance Imaging (MRI) | January 15, 2021
January 15, 2021 — 
Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: National Institute of Allergy and Infectious Diseases, NIH

Novel Coronavirus SARS-CoV-2 Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Image courtesy of  National Institute of Allergy and Infectious Diseases (NIH)

News | Coronavirus (COVID-19) | January 15, 2021
January 15, 2021 — In one of the first studies to examine the impact of the...
Multidisciplinary functionality supports high-capacity utilization and economic efficiency
News | Mobile C-Arms | January 14, 2021
January 14, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
Use of telehealth jumped sharply during the first months of the coronavirus pandemic shutdown, with the approach being used more often for behavioral health services than for medical care, according to a new RAND Corporation study.

Getty Images

News | Teleradiology | January 13, 2021
January 13, 2021 — Use of telehealth jumped sha
The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
News | Artificial Intelligence | January 12, 2021
January 12, 2021 — The U.S.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Getty Images

News | Cardiac Imaging | January 11, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association's...
Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound.

Jeff Elias, MD, is a neurosurgeon at UVA Health and a pioneer in the field of focused ultrasound. Image courtesy of UVA Health

News | Focused Ultrasound Therapy | January 08, 2021
January 8, 2021 — A scalpel-free alternative to brain surgery has the potential to benefit people with...
The FDA is monitoring the potential impact of viral mutations, including an emerging variant from the United Kingdom known as the B.1.1.7 variant, on authorized SARS-CoV-2 molecular tests

Getty Images

News | Coronavirus (COVID-19) | January 08, 2021
January 8, 2021 — The U.S.